United States Government Publishing Office publisher pbl distributor dst United States Congress House of Representatives Committee on Oversight and Reform author aut Government Organization text government publication eng GOVPUB Congressional Committee Materials legislative 2024-09-11 Congress 2022-01-01 monographic harvested born digital 28 digital object pages Y 4.OV 2:C 81/4 https://www.govinfo.gov/app/details/GOVPUB-Y4_OV2-PURL-gpo183446 P0b002ee1c86e7e44 001181253 https://purl.fdlp.gov/GPO/gpo183446 (OCoLC)1329983407 DGPO 2024-09-11 2026-06-26 GOVPUB-Y4_OV2-PURL-gpo183446 machine generated eng fdlp Y4_OV2 GOVPUB-Y4_OV2-PURL-gpo183446 PURL-gpo183446 GOVPUB This content was harvested from online sources of the original hosting or authoring agency and may not reflect current policy. As Federal agencies add publications to their websites, or report new publications to GPO per statutory mandate (44 U.S.C. §§ 1710, 1902-1903), GPO ensures long-term preservation of and access to the content. 2022 UNREPORTEDPUBSSTAFF BIBCONEW 20220614 PERM_INGEST_12292023 gpo183446 https://www.govinfo.gov/app/details/GOVPUB-Y4_OV2-PURL-gpo183446 https://www.govinfo.gov/content/pkg/GOVPUB-Y4_OV2-PURL-gpo183446/pdf/GOVPUB-Y4_OV2-PURL-gpo183446.pdf Coronavirus infections COVID-19 (Disease) Development Government policy Prevention Standards Subsidies Treatment Vaccination Vaccines Vaccines industry United States Emergent BioSolutions. 1016-C (online) United States Congress. House. Committee on Oversight and Reform. Select Subcommittee on the Coronavirus Crisis, creator author. dcu Select Subcommittee on the Coronavirus Crisis, Committee on Oversight and Reform 2022. monographic

print

1 online resource (26 pages) : color illustrations Y 4.OV 2:C 81/4 1016-C (online) text bibliography eng Select Subcommittee on the Coronavirus Crisis, Committee on Oversight and Reform. "Staff report, May 2022." Redacted. Includes bibliographical references (pages 17-26). n-us--- Emergent BioSolutions. Vaccines Development Standards United States Vaccines Standards United States Vaccines industry Government policy United States Vaccines industry Subsidies United States COVID-19 (Disease) Vaccination United States COVID-19 (Disease) Treatment United States COVID-19 (Disease) United States Prevention Coronavirus infections United States Prevention https://purl.fdlp.gov/GPO/gpo183446 https://coronavirus.house.gov/sites/democrats.coronavirus.house.gov/files/Coronavirus%20Vaccine%20Manufacturing%20Failures%20of%20Emergent%20BioSolutions.pdf The